The University of Wisconsin is conducting an islet cell transplant clinical trial for patients with Type I diabetes mellitus. The purpose of this trial is to study the effectiveness of pioglitazone, a medicine which sensitizes the body's cells to insulin, in combination with islet transplant in selected individuals with Type I diabetes mellitus.

 

The links on this page provide detailed information about islet cells, the transplant process and how patients can get involved with the clinical trial.

 

Information About Our Islet Cell Program 

Internet Resources